Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Pegasys for perioperative immune suppression in colon cancer
2024-517619-65-00Phase 2Authorised
- Sponsor
- Region Zealand
- Start
- Sep 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colon cancer and colon adenocarcinoma comparing Pegasys preoperative with Placebo preoperative (2 arms). Planned start Sep 2024; status: authorised.
02
Drugs
interferon alfa
03
Conditions
colon cancercolon adenocarcinoma
Beyond the preview
Go deeper on 2024-517619-65-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517619-65-00.